B4GALT4 antibody
Principal name
B4GALT4 antibody
Alternative names for B4GALT4 antibody
Beta-1,4-GalTase 4, Beta4Gal-T4, b4Gal-T4, Beta-1,4-galactosyltransferase 4, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4
Ncbi ID
9606, NP_003769, NP_003769.1, NP_062778.2, NM_019804, NM_001012018, NM_003778, NM_212543
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), EPair for Elisa (EPair), Immunoprecipitation (IP), Paraffin Sections (P)
Background of B4GALT4 antibody
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: Glcc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-termil hydrophobic sigl sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The enzyme encoded by this gene appears to mainly play a role in glycolipid biosynthesis. Two altertively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].









- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA807809 | B4GALT4 antibody |
||||||
| B4GALT4 mouse monoclonal antibody, clone OTI8B6 (formerly 8B6) | |||||||
![]() |
Mouse | IgG1 | OTI8B6 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+3 additional images |
Highly validated antibody! |
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP309493 | B4GALT4 (transcript variant 2) |
||||
| Recombinant protein of human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (B4GALT4), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP720426 | B4GALT4 (transcript variant 2) |
||||
| Recombinant protein of human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (B4GALT4), transcript variant 2 | |||||
![]() |
Human | > 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€299.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR205179L2V | Lenti ORF particles, B4galt4 (GFP-tagged) - Mouse UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR205179L1V | Lenti ORF particles, B4galt4 (Myc-DDK-tagged) - Mouse UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR206049L2V | Lenti ORF particles, B4galt4 (GFP-tagged ORF) - Rat UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR206049L1V | Lenti ORF particles, B4galt4 (Myc-DDK-tagged ORF) - Rat UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||






+3 additional images


